University of Texas MD Anderson Cancer Center. Department of Investigational Cancer Therapeutics ^Hubs

The Department of Investigational Cancer Therapeutics conducts broad phase I studies across disease boundaries and molecular targets. They strive to provide outstanding patient care while performing innovative phase I trials with new drugs that may eventually improve the management of cancer